Shares of Danaher Corporation (NYSE:DHR – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-five brokerages that are currently covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation, nineteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $228.9130.
Several research firms recently weighed in on DHR. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Barclays decreased their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Argus lowered their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th.
Get Our Latest Research Report on Danaher
Institutional Trading of Danaher
Danaher Trading Up 0.1%
Shares of Danaher stock opened at $195.25 on Monday. Danaher has a 1 year low of $160.93 and a 1 year high of $242.80. The company’s fifty day simple moving average is $188.36 and its 200-day simple moving average is $195.35. The company has a market cap of $137.26 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 2.43 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. As a group, sell-side analysts expect that Danaher will post 8.53 EPS for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Friday, June 26th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Friday, June 26th. Danaher’s payout ratio is 28.42%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
